Assessment of Blood Indices in Systemic Lupus Erythematosus
Launched by ASSIUT UNIVERSITY · Mar 7, 2025
Trial Information
Current as of April 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This case-control study will be conducted at Assiut University Hospital, involving 70 patients diagnosed with SLE according to the 2019 ACR/EULAR classification criteria and 70 healthy controls matched for age and gender. Inclusion criteria include patients aged 18 years or older with SLE, while exclusion criteria include other autoimmune diseases, recent infections, and hematological disorders unrelated to SLE.
Study Tools and Procedures:
Demographic Information: Collect data on age, gender, duration of illness, and relevant medical history.
Clinical Assessment: Disease activity will be...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients aged 18 years or older diagnosed with SLE according to the 2019 ACR/EULAR classification criteria.
- • Healthy controls without any autoimmune diseases or significant comorbidities
- Exclusion Criteria:
- • • Patients with other autoimmune diseases (e.g., rheumatoid arthritis, Sjögren's syndrome).
- • Recent infections or acute inflammatory conditions.
- • Individuals with hematological disorders unrelated to SLE (e.g., leukemia, lymphoma).
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported